Selected article for: "antibody testing and spike protein"

Author: Esmail, Sally; Knauer, Michael J.; Abdoh, Husam; Voss, Courtney; Chin-Yee, Benjamin; Stogios, Peter; Seitova, Almagul; Hutchinson, Ashley; Yusifov, Farhad; Skarina, Tatiana; Evdokimova, Elena; Ackloo, Suzanne; Lowes, Lori; Hedley, Benjamin D.; Bhayana, Vipin; Chin-Yee, Ian; Li, Shawn S.-C.
Title: Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies
  • Cord-id: bw6o2zl1
  • Document date: 2021_5_12
  • ID: bw6o2zl1
    Snippet: We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ∼98% sensitivity. Furthermore, we
    Document: We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ∼98% sensitivity. Furthermore, we found that the strength of the S-RBD antibody response measured by the agglutination assay correlated with the efficiency of the plasma in blocking RBD binding to the angiotensin-converting enzyme 2 in a surrogate neutralization assay, suggesting that the agglutination assay might be used to identify individuals with virus-neutralizing antibodies. Intriguingly, we found that >92% of patients had detectable antibodies on the day of a positive viral RNA test, suggesting that the agglutination antibody test might complement RNA testing for the diagnosis of SARS-CoV-2 infection.

    Search related documents:
    Co phrase search for related documents
    • accurate assessment and active infection: 1, 2
    • accurate assessment and acute infection: 1
    • accurate assessment and longitudinal analysis: 1, 2
    • accurate highly sensitive and acid amplification test: 1
    • accurate highly sensitive and acute infection: 1, 2
    • accurate highly sensitive assay and acute infection: 1
    • accurate rapid and acid amplification test: 1, 2, 3, 4, 5, 6
    • accurate rapid and active infection: 1, 2, 3
    • accurate rapid and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accurate rapid and acute infection diagnose: 1, 2, 3
    • accurate rapid and low resource: 1, 2, 3, 4, 5, 6
    • acid amplification test and active infection: 1
    • acid amplification test and acute infection: 1, 2, 3, 4, 5, 6, 7
    • active infection and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active infection and acute infection diagnose: 1, 2
    • active infection and longitudinal analysis: 1, 2, 3
    • active infection and low resource: 1, 2, 3
    • active infection and low resource high: 1
    • acute infection and low resource: 1, 2, 3, 4